APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digital Pathology AI-Assisted Diagnostic System

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Digital Pathology AI-Assisted Diagnostic System Market Outlook and Growth Opportunities 2026

15 January 2026190 pages

Choose your research edition.

Industry ResearchDigital Pathology AI-Assisted Diagnostic System Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Pathology AI-Assisted Diagnostic System Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Digital Pathology AI-Assisted Diagnostic System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Pathology AI-Assisted Diagnostic System Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Pathology AI-Assisted Diagnostic System Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Digital Pathology AI-Assisted Diagnostic System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Digital Pathology AI-Assisted Diagnostic System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Digital Pathology AI-Assisted Diagnostic System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digital Pathology AI-Assisted Diagnostic System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Digital Pathology AI-Assisted Diagnostic System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Digital Pathology AI-Assisted Diagnostic System market include Lunit, VUNO, Inc., Konfoong Bioinformation Tech, Techcyte, Hologic, Canon Medical, ANNALISE-AI PTY LTD, CellsVision and Dipath, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Digital Pathology AI-Assisted Diagnostic System market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Digital Pathology AI-Assisted Diagnostic System and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Digital Pathology AI-Assisted Diagnostic System revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Digital Pathology AI-Assisted Diagnostic System market.

Digital Pathology AI-Assisted Diagnostic System Segment by Company

Lunit

VUNO, Inc.

Konfoong Bioinformation Tech

Techcyte

Hologic

Canon Medical

ANNALISE-AI PTY LTD

CellsVision

Dipath

Cytowiz Incorporated

Wuhan Zhongji Biotech

Digital Pathology AI-Assisted Diagnostic System Segment by Type

Equipment

Software

Digital Pathology AI-Assisted Diagnostic System Segment by Application

Cervix

Breast

Gastrointestinal

Other

Digital Pathology AI-Assisted Diagnostic System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Digital Pathology AI-Assisted Diagnostic System status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Digital Pathology AI-Assisted Diagnostic System key companies, revenue, market share, and recent developments.

3. To split the Digital Pathology AI-Assisted Diagnostic System breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Digital Pathology AI-Assisted Diagnostic System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Digital Pathology AI-Assisted Diagnostic System significant trends, drivers, influence factors in global and regions.

6. To analyze Digital Pathology AI-Assisted Diagnostic System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Pathology AI-Assisted Diagnostic System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Pathology AI-Assisted Diagnostic System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Pathology AI-Assisted Diagnostic System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digital Pathology AI-Assisted Diagnostic System industry.

Chapter 3: Detailed analysis of Digital Pathology AI-Assisted Diagnostic System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Digital Pathology AI-Assisted Diagnostic System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Digital Pathology AI-Assisted Diagnostic System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Digital Pathology AI-Assisted Diagnostic System Industry Trends Table 2. Digital Pathology AI-Assisted Diagnostic System Industry Drivers Table 3. Digital Pathology AI-Assisted Diagnostic System Industry Opportunities and Challenges Table 4. Digital Pathology AI-Assisted Diagnostic System Industry Restraints Table 5. Global Digital Pathology AI-Assisted Diagnostic System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Digital Pathology AI-Assisted Diagnostic System Revenue Share by Company (2021-2026) Table 7. Global Digital Pathology AI-Assisted Diagnostic System Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Digital Pathology AI-Assisted Diagnostic System Key Company Manufacturing Base & Headquarters Table 9. Global Digital Pathology AI-Assisted Diagnostic System Company, Product Type & Application Table 10. Global Digital Pathology AI-Assisted Diagnostic System Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Digital Pathology AI-Assisted Diagnostic System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Equipment Table 15. Significant Companies of Software Table 16. Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type (2021-2026) Table 20. Global Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Cervix Table 22. Significant Companies of Breast Table 23. Significant Companies of Gastrointestinal Table 24. Significant Companies of Other Table 25. Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application (2021-2026) Table 29. Global Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application (2027-2032) Table 30. Global Digital Pathology AI-Assisted Diagnostic System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Region (2021-2026) Table 33. Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Region (2027-2032) Table 35. Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Digital Pathology AI-Assisted Diagnostic System Sales Value Market Share by Country (2021-2026) Table 38. Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Digital Pathology AI-Assisted Diagnostic System Sales Value Market Share by Country (2027-2032) Table 40. Lunit Company Information Table 41. Lunit Business Overview Table 42. Lunit Digital Pathology AI-Assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Lunit Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 44. Lunit Recent Development Table 45. VUNO, Inc. Company Information Table 46. VUNO, Inc. Business Overview Table 47. VUNO, Inc. Digital Pathology AI-Assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. VUNO, Inc. Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 49. VUNO, Inc. Recent Development Table 50. Konfoong Bioinformation Tech Company Information Table 51. Konfoong Bioinformation Tech Business Overview Table 52. Konfoong Bioinformation Tech Digital Pathology AI-Assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Konfoong Bioinformation Tech Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 54. Konfoong Bioinformation Tech Recent Development Table 55. Techcyte Company Information Table 56. Techcyte Business Overview Table 57. Techcyte Digital Pathology AI-Assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Techcyte Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 59. Techcyte Recent Development Table 60. Hologic Company Information Table 61. Hologic Business Overview Table 62. Hologic Digital Pathology AI-Assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Hologic Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 64. Hologic Recent Development Table 65. Canon Medical Company Information Table 66. Canon Medical Business Overview Table 67. Canon Medical Digital Pathology AI-Assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Canon Medical Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 69. Canon Medical Recent Development Table 70. ANNALISE-AI PTY LTD Company Information Table 71. ANNALISE-AI PTY LTD Business Overview Table 72. ANNALISE-AI PTY LTD Digital Pathology AI-Assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. ANNALISE-AI PTY LTD Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 74. ANNALISE-AI PTY LTD Recent Development Table 75. CellsVision Company Information Table 76. CellsVision Business Overview Table 77. CellsVision Digital Pathology AI-Assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. CellsVision Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 79. CellsVision Recent Development Table 80. Dipath Company Information Table 81. Dipath Business Overview Table 82. Dipath Digital Pathology AI-Assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Dipath Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 84. Dipath Recent Development Table 85. Cytowiz Incorporated Company Information Table 86. Cytowiz Incorporated Business Overview Table 87. Cytowiz Incorporated Digital Pathology AI-Assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Cytowiz Incorporated Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 89. Cytowiz Incorporated Recent Development Table 90. Wuhan Zhongji Biotech Company Information Table 91. Wuhan Zhongji Biotech Business Overview Table 92. Wuhan Zhongji Biotech Digital Pathology AI-Assisted Diagnostic System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Wuhan Zhongji Biotech Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 94. Wuhan Zhongji Biotech Recent Development Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Digital Pathology AI-Assisted Diagnostic System Product Image Figure 2. Global Digital Pathology AI-Assisted Diagnostic System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Pathology AI-Assisted Diagnostic System Market Size (2021-2032) & (US$ Million) Figure 4. Global Digital Pathology AI-Assisted Diagnostic System Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Equipment Image Figure 8. Software Image Figure 9. Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Digital Pathology AI-Assisted Diagnostic System Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type (2021-2032) Figure 12. Cervix Image Figure 13. Breast Image Figure 14. Gastrointestinal Image Figure 15. Other Image Figure 16. Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Digital Pathology AI-Assisted Diagnostic System Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application (2021-2032) Figure 19. Global Digital Pathology AI-Assisted Diagnostic System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Digital Pathology AI-Assisted Diagnostic System Sales Value (2021-2032) & (US$ Million) Figure 22. North America Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Digital Pathology AI-Assisted Diagnostic System Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Digital Pathology AI-Assisted Diagnostic System Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Digital Pathology AI-Assisted Diagnostic System Sales Value (2021-2032) & (US$ Million) Figure 28. South America Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Digital Pathology AI-Assisted Diagnostic System Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Equipment
  • Software
Applications
  • Cervix
  • Breast
  • Gastrointestinal
  • Other
Companies covered
  • Lunit
  • VUNO, Inc.
  • Konfoong Bioinformation Tech
  • Techcyte
  • Hologic
  • Canon Medical
  • ANNALISE-AI PTY LTD
  • CellsVision
  • Dipath
  • Cytowiz Incorporated
  • Wuhan Zhongji Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Digital Pathology AI-Assisted Diagnostic System Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Digital Pathology AI-Assisted Diagnostic System Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Digital Pathology AI-Assisted Diagnostic System Market Dynamics
  1. 2.1 Digital Pathology AI-Assisted Diagnostic System Industry Trends
  2. 2.2 Digital Pathology AI-Assisted Diagnostic System Industry Drivers
  3. 2.3 Digital Pathology AI-Assisted Diagnostic System Industry Opportunities and Challenges
  4. 2.4 Digital Pathology AI-Assisted Diagnostic System Industry Restraints
3 Digital Pathology AI-Assisted Diagnostic System Market by Company
  1. 3.1 Global Digital Pathology AI-Assisted Diagnostic System Company Revenue Ranking in 2025
  2. 3.2 Global Digital Pathology AI-Assisted Diagnostic System Revenue by Company (2021-2026)
  3. 3.3 Global Digital Pathology AI-Assisted Diagnostic System Company Ranking (2024-2026)
  4. 3.4 Global Digital Pathology AI-Assisted Diagnostic System Company Manufacturing Base and Headquarters
  5. 3.5 Global Digital Pathology AI-Assisted Diagnostic System Company Product Type and Application
  6. 3.6 Global Digital Pathology AI-Assisted Diagnostic System Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Digital Pathology AI-Assisted Diagnostic System Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Digital Pathology AI-Assisted Diagnostic System Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Digital Pathology AI-Assisted Diagnostic System Market by Type
  1. 4.1 Digital Pathology AI-Assisted Diagnostic System Type Introduction
  2. 4.1.1 Equipment
  3. 4.1.2 Software
  4. 4.2 Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Type
  5. 4.2.1 Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Type (2021-2032)
  7. 4.2.3 Global Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type (2021-2032)
5 Digital Pathology AI-Assisted Diagnostic System Market by Application
  1. 5.1 Digital Pathology AI-Assisted Diagnostic System Application Introduction
  2. 5.1.1 Cervix
  3. 5.1.2 Breast
  4. 5.1.3 Gastrointestinal
  5. 5.1.4 Other
  6. 5.2 Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Application
  7. 5.2.1 Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Application (2021-2032)
  9. 5.2.3 Global Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application (2021-2032)
6 Digital Pathology AI-Assisted Diagnostic System Regional Value Analysis
  1. 6.1 Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Region (2021-2032)
  3. 6.2.1 Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Region: 2021-2026
  4. 6.2.2 Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Digital Pathology AI-Assisted Diagnostic System Sales Value (2021-2032)
  7. 6.3.2 North America Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Digital Pathology AI-Assisted Diagnostic System Sales Value (2021-2032)
  10. 6.4.2 Europe Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Digital Pathology AI-Assisted Diagnostic System Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Digital Pathology AI-Assisted Diagnostic System Sales Value (2021-2032)
  16. 6.6.2 South America Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Digital Pathology AI-Assisted Diagnostic System Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Country, 2025 VS 2032
7 Digital Pathology AI-Assisted Diagnostic System Country-level Value Analysis
  1. 7.1 Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Country (2021-2032)
  3. 7.2.1 Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Country (2021-2026)
  4. 7.2.2 Global Digital Pathology AI-Assisted Diagnostic System Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Digital Pathology AI-Assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Digital Pathology AI-Assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lunit
  2. 8.1.1 Lunit Company Information
  3. 8.1.2 Lunit Business Overview
  4. 8.1.3 Lunit Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lunit Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  6. 8.1.5 Lunit Recent Developments
  7. 8.2 VUNO, Inc.
  8. 8.2.1 VUNO, Inc. Company Information
  9. 8.2.2 VUNO, Inc. Business Overview
  10. 8.2.3 VUNO, Inc. Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  11. 8.2.4 VUNO, Inc. Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  12. 8.2.5 VUNO, Inc. Recent Developments
  13. 8.3 Konfoong Bioinformation Tech
  14. 8.3.1 Konfoong Bioinformation Tech Company Information
  15. 8.3.2 Konfoong Bioinformation Tech Business Overview
  16. 8.3.3 Konfoong Bioinformation Tech Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Konfoong Bioinformation Tech Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  18. 8.3.5 Konfoong Bioinformation Tech Recent Developments
  19. 8.4 Techcyte
  20. 8.4.1 Techcyte Company Information
  21. 8.4.2 Techcyte Business Overview
  22. 8.4.3 Techcyte Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Techcyte Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  24. 8.4.5 Techcyte Recent Developments
  25. 8.5 Hologic
  26. 8.5.1 Hologic Company Information
  27. 8.5.2 Hologic Business Overview
  28. 8.5.3 Hologic Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hologic Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  30. 8.5.5 Hologic Recent Developments
  31. 8.6 Canon Medical
  32. 8.6.1 Canon Medical Company Information
  33. 8.6.2 Canon Medical Business Overview
  34. 8.6.3 Canon Medical Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Canon Medical Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  36. 8.6.5 Canon Medical Recent Developments
  37. 8.7 ANNALISE-AI PTY LTD
  38. 8.7.1 ANNALISE-AI PTY LTD Company Information
  39. 8.7.2 ANNALISE-AI PTY LTD Business Overview
  40. 8.7.3 ANNALISE-AI PTY LTD Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ANNALISE-AI PTY LTD Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  42. 8.7.5 ANNALISE-AI PTY LTD Recent Developments
  43. 8.8 CellsVision
  44. 8.8.1 CellsVision Company Information
  45. 8.8.2 CellsVision Business Overview
  46. 8.8.3 CellsVision Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CellsVision Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  48. 8.8.5 CellsVision Recent Developments
  49. 8.9 Dipath
  50. 8.9.1 Dipath Company Information
  51. 8.9.2 Dipath Business Overview
  52. 8.9.3 Dipath Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dipath Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  54. 8.9.5 Dipath Recent Developments
  55. 8.10 Cytowiz Incorporated
  56. 8.10.1 Cytowiz Incorporated Company Information
  57. 8.10.2 Cytowiz Incorporated Business Overview
  58. 8.10.3 Cytowiz Incorporated Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cytowiz Incorporated Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  60. 8.10.5 Cytowiz Incorporated Recent Developments
  61. 8.11 Wuhan Zhongji Biotech
  62. 8.11.1 Wuhan Zhongji Biotech Company Information
  63. 8.11.2 Wuhan Zhongji Biotech Business Overview
  64. 8.11.3 Wuhan Zhongji Biotech Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Wuhan Zhongji Biotech Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  66. 8.11.5 Wuhan Zhongji Biotech Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst